A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome

August 2021 in “ Frontiers in Pharmacology ”

Osama A. A. Ahmed, Noura A. Hassan, Ahmad S. Azhar, Mahmoud M. El‐Mas, Hany M. El‐Bassossy

Studysummary This study found that a nano-preparation of quercetin, using a self-nanoemulsifying drug delivery system, was more effective than standard quercetin in reducing cardiac complications and tissue damage in rats with metabolic syndrome, although both formulations similarly reduced oxidative and inflammatory markers.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research RP-HPLC Determination of Quercetin in a Novel D-Alpha-Tocopherol Polyethylene Glycol 1000 Succinate Based SNEDDS Formulation: Pharmacokinetics in Rat Plasma

21 citations , March 2021 in “Molecules”

This study found that a new quercetin-loaded self-nanoemulsifying drug delivery system improved quercetin bioavailability by 149.8% compared to its suspension in rats.

research A Comprehensive Review on Metabolic Syndrome

1341 citations , January 2014 in “Cardiology Research and Practice”

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

research Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial

36 citations , January 2014 in “Evidence-based Complementary and Alternative Medicine”

This study found that men with androgenetic alopecia treated with pumpkin seed oil for 24 weeks experienced a notable 40% increase in hair count compared to a 10% increase with a placebo.